Cargando…
Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
COVID-19 has rapidly spread worldwide and incidences of hospitalisation from respiratory distress are significant. While a vaccine is in the pipeline, there is urgency for therapeutic options to address the immune dysregulation, hyperinflammation and oxidative stress that can lead to death. Given th...
Autores principales: | Timpani, Cara A., Rybalka, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824470/ https://www.ncbi.nlm.nih.gov/pubmed/33375288 http://dx.doi.org/10.3390/ph14010015 |
Ejemplares similares
-
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
por: Kourakis, Stephanie, et al.
Publicado: (2020) -
Micro (mRNA) molecules could pack a big punch in the fight against neuromuscular disease
por: Rybalka, Emma, et al.
Publicado: (2020) -
CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020) -
Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020) -
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)